We've been working together to make our support services more accessible to the Deaf community.

The blood-brain barrier acts as a gatekeeper restricting what can and cannot reach the brain. Researchers are now designing the next generation of antibody treatments to cross the blood-brain barrier more effectively.

Professor Fiona Carragher, Chief Policy and Research Officer at Alzheimer’s Society, comments on the Chancellor's Autumn Budget:

A new study, funded by Alzheimer’s Society, has identified three existing medications that could be repurposed to treat or prevent Alzheimer’s disease. 

Researchers are studying whether existing, safe medicines could be adapted to treat dementia. This is known as drug repurposing, and it offers fresh hope for finding effective dementia treatments sooner.

Learn more about our new CEO, who brings almost 27 years of experience from working in the Civil Service.

University College London has published a study, part funded by Alzheimer’s Society’s Heather Corrie Impact Fund, which shows it’s possible to cut the time for diagnostic MRI scans for dementia to one third of their standard length.  

Football fans with dementia have been nominated to appear as mascots on 9 October at the England and Wales friendly game at Wembley, as part of the partnership between Alzheimer’s Society and The FA.

For the second consecutive year, the UK’s leading dementia charity, Alzheimer’s Society, has united the world of sport to raise awareness of dementia throughout World Alzheimer’s Month.

Our new brand advertising campaign ‘A Personal Appeal’ launched this week across TV, cinema, radio, podcasts and social media.